Overview
Abstract Submission Guidelines
The Scientific Committee of PSN 39 invites submission of abstracts for oral, rapid oral, e-poster, and operative video presentations. All abstracts must be submitted in English through the official website. Please read these guidelines carefully before submitting. The Scientific Committee reserves the right to make all final decisions regarding acceptance and presentation format.
- The deadline for abstract submission is August 15, 2026
- All abstracts must be submitted in English through the official website
- There is no limit to the number of abstracts an author may submit
-
Four presentation formats are available: oral, rapid oral, e-poster, and operative video.
Authors may indicate a preferred format; however, the Scientific Committee reserves the right to make the final decision
- All abstracts must include completed results and conclusions at the time of submission. Abstracts based on incomplete, uncollected, or unanalyzed data will not be considered
- All accepted abstracts will be published as submitted in a biomedical journal to be announced in due course
- Abstracts may be withdrawn only during the official withdrawal period from September 25 to September 30, 2026. After this period, withdrawal requests will not be accepted
- Requests for withdrawal during the permitted period must be submitted via email to the Scientific Committee
- Presenting authors must complete registration for PSN 39 by October 5, 2026. Abstracts without a registered presenter by this deadline will be removed from the program
- The Scientific Committee retains full authority to assign the final presentation format (oral or poster), irrespective of the author's stated preference
Abstracts may be edited up to the submission deadline of August 15, 2026. After this date, no revisions or modifications will be permitted.
Important:
The organizing committee will not make corrections to typographical or spelling errors, title formatting, or similar issues. Full responsibility rests with the submitting author to thoroughly review and ensure the accuracy, clarity, and proper formatting of all submitted content prior to submission.
Submitter & Presenter Responsibilities
-
Submitting Author: The submitting author is responsible for submitting the abstract and will serve as the primary point of contact for all correspondence. The submitting author must also be the presenting author. Submissions on behalf of others are not permitted
- Requests for changes in authorship or presenter details will not be accommodated
- Abstracts must not contain any form of advertising, trade names, or product-specific promotional content. Generic names and terminology must be used throughout
- All presenters — whether for oral or poster presentations — are required to present in person at the conference venue
- Submitters are responsible for ensuring the accuracy and completeness of all author and presenter contact details at the time of submission
- Poster presenters are required to submit an electronic version of their poster. This version will be displayed both on-site and on the official conference platform
Abstract Structure for Oral & Poster Presentations
Note:
The following structure applies to all oral and poster submission categories. Ensure all required fields are completed before submission.
-
Category
Select one category that best aligns with your abstract:
- Case Reports and Case Series
- Research and Original Articles
- Systematic Reviews and Meta-analyses
- Quality Improvement Projects or Clinical Audits
-
Type of Presentation
- Oral
- Rapid Oral
- E-Poster
- Operative Video
-
Title
Use title case with each major word capitalized. Maximum length is 25 words
-
Background
Provide the rationale for the study, clearly explaining why it was conducted or documented
-
Objective
State the purpose of the study clearly. Specify primary and secondary objectives where applicable
-
Methodology
Include study design, setting, duration, sampling method, sample size, inclusion and exclusion criteria, and data analysis techniques.
For quantitative studies, describe statistical methods in clear and simple terms.
For systematic reviews and meta-analyses, include search strategy and databases used
-
Results
Summarize key findings with relevant frequencies and percentages for assessed variables. Use appropriate units and apply correct statistical reporting where necessary
-
Conclusion
Provide a clear conclusion that directly addresses the research objective. Do not include recommendations. Avoid repeating results verbatim
-
Keywords
Provide at least three relevant keywords
-
Approval or Registration Number
For original research: include IRB approval or reference number.
For systematic reviews and meta-analyses: include PROSPERO registration number
-
Use of Artificial Intelligence
Disclose any use of artificial intelligence and specify how it was applied
-
Conflict of Interest
Declare any potential conflicts, including funding, honoraria, affiliations, or personal relationships. If none, state "none to declare"
-
Ethical Approval
For original research and clinical studies, include the name of the Institutional Review Board or Ethics Committee along with the approval number
-
Funding
Clearly state all sources of funding. If none, please write so
-
Submission Declaration
By submitting an abstract, the author confirms all requirements — see the Declaration section below
Submission Declaration
- All authors have reviewed and approved the abstract
- Permission is granted for publication of the abstract as submitted
- Permission is granted to record and publicly host the presentation on the official conference platform for approximately one year
- The presenting author or a co-author will register for and present at the conference
- Presentation at PSN 39 does not constitute prior publication for submission to peer-reviewed journals
- All permission requirements are mandatory and non-negotiable
Review Criteria for Abstracts (Oral & Poster)
| # |
Criterion |
Description |
| 1 |
Originality & Contribution to Local Disease Burden |
Priority given to studies addressing neurosurgical conditions most prevalent in Pakistan, with clear implications for improving patient outcomes in local settings |
| 2 |
Scientific Merit |
Assessment of the originality, significance, and contribution to the field of neurosurgery. Preference for work that advances current knowledge, challenges existing practices, or introduces novel concepts |
| 3 |
Methodological Rigor |
Assessment of study design, appropriateness of methodology, sampling strategy, inclusion/exclusion criteria, and statistical analysis. Studies should demonstrate scientific validity, transparency, and reproducibility |
| 4 |
Clarity & Completeness of Data Presentation |
Evaluation of how clearly the abstract presents objectives, methods, results, and conclusions, with accurate and complete reporting that allows for meaningful interpretation and potential replication |
| 5 |
Conclusion & Impact |
Evaluation of whether conclusions are justified by the results and whether the study provides meaningful insights or potential impact on neurosurgical practice or future research |
Operative Video Session – Submission Guidelines
Eligibility
- Resident trainees in Neurosurgery
- Early-career neurosurgeons (within 7 years of their exit-exam success)
Selection Process: All submissions will undergo peer review by the Scientific Committee. Approximately 10–15 high-quality video submissions will be shortlisted for presentation based on predefined evaluation criteria.
Video Requirements
Max Duration
6 minutes (incl. ~2 min discussion)
Max File Size
150 MB per file / 1 GB total
Accepted Formats
MP4, MOV, WMV, AVI, FLV
Narration
Voice-over mandatory; no background music
Opening Slide Requirement:
The opening slide must clearly display the video title, full list of authors with academic credentials, and institutional affiliations.
Recommended Structure
- Title and disclosures
- Clinical presentation
- Preoperative imaging
- Operative strategy
- Intraoperative video footage
- Postoperative imaging and outcomes
- Discussion and key learning points
- References
Additional Submission Materials
- Abstract of up to 250 words, including 3–5 keywords, disclosures, and a statement confirming originality
- A time-stamped transcript that corresponds with the video narration
- Optional figures or tables may be included, provided appropriate copyright permissions are obtained and all materials are original
Review Criteria
- Technical quality and clarity of the video
- Clinical relevance and complexity of the case
- Completeness of outcomes and follow-up information
- Overall quality of video production and narration
- Originality, innovation, and educational value
- Decisions regarding abstract acceptance and presentation category will be communicated via the official conference email between September 21–25, 2026
- All submitting and presenting authors of accepted abstracts are required to prepare their presentations using the official templates provided. No alternative formats will be accepted
- Oral presentations must follow the designated PowerPoint template and poster presentations must use the specified poster template
- All submitting and presenting authors must complete conference registration by October 05, 2026. Abstracts without a registered presenter by this deadline will be withdrawn from the program
- Final presentations (PPTs, posters, or operative videos) must be uploaded to the conference portal by October 15, 2026
- For any technical issues or queries regarding uploads, authors should contact General Enquiries
All accepted abstracts will be automatically considered eligible for the following awards. In-person presentation is mandatory to be eligible. Awards will be presented to the presenting author only.
Outstanding Oral Presentation Award
Three recipients
Excellence in E-Poster Presentation Award
Three recipients
Best Video Presentation Award
One recipient